Aurora Cannabis Soars with 29% Revenue Growth in Q2 2025, Driven by Global Medical Cannabis Expansion

Canadian medical marijuana giant Aurora Cannabis Inc. reported strong second-quarter financial results, with revenue reaching CA$81.1 million, driven by robust growth in its global medical cannabis business. The company’s international revenue surged 93%, exceeding Canadian medical revenue for the first time, highlighting its strategic focus on expanding into lucrative international markets. Aurora’s Q2 2025 performance also saw a significant increase in adjusted EBITDA and a positive outlook for the coming quarters.

Scroll to Top